Payer harmony for Lilly’s Covid mAb?

Eli Lilly’s investigational monoclonal antibody (mAb) bamlanivimab, which recently was issued emergency use authorization (EUA) by the FDA for Covid-19, is unlikely to face payer pushback, despite its broad label, GlobalData reports. The data and analytics company notes that drug prices have […]

Read More

Analysts: Global API market to reach $306B by 2027

According to a recent report by Polaris Market Research, the worldwide active pharmaceutical ingredient (API) market valuation is projected to reach $306.1 billion by 2027. An increase in occurrences of chronic ailments such as cardiovascular diseases (CVDs), arthritis and diabetes, […]

Read More

Amazon moves full-bore into pharmacy space

In its biggest move yet in the tech giant’s steadily building but aggressive entrance into healthcare and the lucrative pharmacy market, Amazon today officially launched two new ways to help customers purchase their prescription medications. One is the unveiling of Amazon […]

Read More

Catalent-cell therapy manufacturer deal now complete

Following an agreement Pharmaceutical Commerce originally reported being reached in late October, Catalent Pharma Solutions, Inc. has officially completed its acquisition of Bone Therapeutics’ manufacturing subsidiary, Skeletal Cell Therapy Support SA (SCTS), for $14.2 million USD ($12 million EUR). With the transaction […]

Read More

Antares Vision strengthens traceability position

Italian multinational Antares Vision, which offers customized inspection and track-and-trace systems, has been selected by the French judicial authority as the winner of the tender for the purchase—directly or indirectly through its subsidiaries—of the assets of the French company Adents […]

Read More

UK’s Envision lands launch expert Two Labs

Envision Pharma Group, a UK-based scientific communications company, has acquired Two Labs, a strategic consulting and commercialization provider with a footprint in the US pharma domestic market. Two Labs is known for helping pharma companies develop and execute customized launch strategies […]

Read More